top logo
Taisuke MURAKAMI, Ph D
murakami picture
  • B.Pharm. : Faculty of Pharmacy, Tokyo University
    of Pharmacy and Life Science, Japan (2002)
  • M.Life Sc. : Graduate School of Life Science,
    Tokyo University of Pharmacy and Life Science,
    Japan (2004)
  • Ph.D. (Biochemistry) : Juntendo University,
    Graduate School of Medicine, Japan

Current Research Projects

  1. Effects of antibacterial peptides on endotoxin shock

Publications

  • Murakami. T, Suzuki K, Tamura H, Nagaoka I: Suppressive actions of resolvin D1 on the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice. Exp Ther Med 2: 57-61, 2011.
  • Murakami T, Obata T, Kuwahara-Arai K, Tamura H, Hiramatsu K, Nagaoka I: Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice. Int Immunol 21: 905-912, 2009.
  • Murakami T, Yomogida S, Someya A, Kuwahara-Arai K, Tamura H, Nagaoka I: Antibacterial cathelicidin peptide CAP11 suppresses the anandamide production from lipopolysaccharide-stimulated mononuclear phagocytes. FEBS Lett 581: 140-144, 2007.
  • Hozumi H, Adachi Y, Murakami T, Miura NN, Ohno N: Increment of plasma soluble CD14 level in carrageenan-primed endotoxin shock model mice. Biol Pharm Bull 29: 1015-21, 2006.